The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Donald P. Tashkin

David Geffen School of Medicine at UCLA

Los Angeles

CA 90095

USA

[email]@*.ucla.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA. 2012
  • Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles, 10833 Le Conte Ave, USA. 2000 - 2011
  • Division of Pulmonary and Critical Care, David Geffen School of Medicine at UCLA, California 90095-1690, USA. 2010
  • David Geffen School of Medicine, Division of Pulmonary and Critical Care Medicine, UCLA, Los Angeles, California, USA. 2003 - 2010
  • University of California at Los Angeles, Los Angeles, USA. 2006

References

  1. Efficacy and safety characteristics of mometasone furoate/formoterol fumarate fixed-dose combination in subjects with moderate to very severe COPD: findings from pooled analysis of two randomized, 52-week placebo-controlled trials. Tashkin, D.P., Doherty, D.E., Kerwin, E., Matiz-Bueno, C.E., Knorr, B., Shekar, T., Gates, D., Staudinger, H. Int. J. Chron. Obstruct. Pulmon. Dis (2012) [Pubmed]
  2. Efficacy and safety of a fixed-dose combination of mometasone furoate and formoterol fumarate in subjects with moderate to very severe COPD: results from a 52-week Phase III trial. Tashkin, D.P., Doherty, D.E., Kerwin, E., Matiz-Bueno, C.E., Knorr, B., Shekar, T., Banerjee, S., Staudinger, H. Int. J. Chron. Obstruct. Pulmon. Dis (2012) [Pubmed]
  3. Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trial. Tashkin, D.P., Rennard, S., Hays, J.T., Ma, W., Lawrence, D., Lee, T.C. Chest (2011) [Pubmed]
  4. Combined treatment with formoterol and tiotropium is more efficacious than treatment with tiotropium alone in patients with chronic obstructive pulmonary disease, regardless of smoking status, inhaled corticosteroid use, baseline severity, or gender. Tashkin, D.P., Varghese, S.T. Pulm. Pharmacol. Ther (2011) [Pubmed]
  5. Budesonide and formoterol in a single pressurized metered-dose inhaler for treatment of COPD. Tashkin, D.P. Expert. Rev. Respir. Med (2010) [Pubmed]
  6. Impact of tiotropium on the course of moderate-to-very severe chronic obstructive pulmonary disease: the UPLIFT trial. Tashkin, D.P. Expert. Rev. Respir. Med (2010) [Pubmed]
  7. Long-acting anticholinergic use in chronic obstructive pulmonary disease: efficacy and safety. Tashkin, D.P. Curr. Opin. Pulm. Med (2010) [Pubmed]
  8. Long-term efficacy of tiotropium in relation to smoking status in the UPLIFT trial. Tashkin, D.P., Celli, B., Kesten, S., Lystig, T., Mehra, S., Decramer, M. Eur. Respir. J. (2010) [Pubmed]
  9. Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents. Tashkin, D.P., Fabbri, L.M. Respir. Res. (2010) [Pubmed]
  10. Preventing and managing exacerbations in COPD--critical appraisal of the role of tiotropium. Tashkin, D.P. Int. J. Chron. Obstruct. Pulmon. Dis (2010) [Pubmed]
  11. Indacaterol maleate for the treatment of chronic obstructive pulmonary disease. Tashkin, D.P. Expert. Opin. Pharmacother (2010) [Pubmed]
  12. Effect of tiotropium in men and women with COPD: results of the 4-year UPLIFT trial. Tashkin, D., Celli, B., Kesten, S., Lystig, T., Decramer, M. Respir. Med (2010) [Pubmed]
  13. Formoterol and tiotropium compared with tiotropium alone for treatment of COPD. Tashkin, D.P., Pearle, J., Iezzoni, D., Varghese, S.T. COPD (2009) [Pubmed]
  14. Smoking cessation in chronic obstructive pulmonary disease. Tashkin, D.P., Murray, R.P. Respir. Med (2009) [Pubmed]
  15. Nebulized formoterol provides added benefits to tiotropium treatment in chronic obstructive pulmonary disease. Tashkin, D.P., Hanania, N.A., McGinty, J., Denis-Mize, K., Chaudry, I. Adv. Ther (2009) [Pubmed]
  16. Effects of arformoterol twice daily, tiotropium once daily, and their combination in patients with COPD. Tashkin, D.P., Donohue, J.F., Mahler, D.A., Huang, H., Goodwin, E., Schaefer, K., Hanrahan, J.P., Andrews, W.T. Respir. Med (2009) [Pubmed]
  17. Does smoking marijuana increase the risk of chronic obstructive pulmonary disease?. Tashkin, D.P. CMAJ (2009) [Pubmed]
  18. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. Tashkin, D.P., Celli, B., Senn, S., Burkhart, D., Kesten, S., Menjoge, S., Decramer, M. N. Engl. J. Med. (2008) [Pubmed]
  19. Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: a placebo-controlled trial. Tashkin, D.P., Littner, M., Andrews, C.P., Tomlinson, L., Rinehart, M., Denis-Mize, K. Respir. Med (2008) [Pubmed]
  20. Bronchodilator responsiveness in patients with COPD. Tashkin, D.P., Celli, B., Decramer, M., Liu, D., Burkhart, D., Cassino, C., Kesten, S. Eur. Respir. J. (2008) [Pubmed]
  21. Efficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in patients with moderate to very severe chronic obstructive pulmonary disease: results of a 6-month randomized clinical trial. Tashkin, D.P., Rennard, S.I., Martin, P., Ramachandran, S., Martin, U.J., Silkoff, P.E., Goldman, M. Drugs (2008) [Pubmed]
  22. Comparing COPD treatment: nebulizer, metered dose inhaler, and concomitant therapy. Tashkin, D.P., Klein, G.L., Colman, S.S., Zayed, H., Schonfeld, W.H. Am. J. Med. (2007) [Pubmed]
  23. Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease. Tashkin, D.P., Elashoff, R., Clements, P.J., Roth, M.D., Furst, D.E., Silver, R.M., Goldin, J., Arriola, E., Strange, C., Bolster, M.B., Seibold, J.R., Riley, D.J., Hsu, V.M., Varga, J., Schraufnagel, D., Theodore, A., Simms, R., Wise, R., Wigley, F., White, B., Steen, V., Read, C., Mayes, M., Parsley, E., Mubarak, K., Connolly, M.K., Golden, J., Olman, M., Fessler, B., Rothfield, N., Metersky, M., Khanna, D., Li, N., Li, G. Am. J. Respir. Crit. Care Med. (2007) [Pubmed]
  24. Cyclophosphamide versus placebo in scleroderma lung disease. Tashkin, D.P., Elashoff, R., Clements, P.J., Goldin, J., Roth, M.D., Furst, D.E., Arriola, E., Silver, R., Strange, C., Bolster, M., Seibold, J.R., Riley, D.J., Hsu, V.M., Varga, J., Schraufnagel, D.E., Theodore, A., Simms, R., Wise, R., Wigley, F., White, B., Steen, V., Read, C., Mayes, M., Parsley, E., Mubarak, K., Connolly, M.K., Golden, J., Olman, M., Fessler, B., Rothfield, N., Metersky, M. N. Engl. J. Med. (2006) [Pubmed]
  25. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding. Tashkin, D.P. Am. J. Med. (2006) [Pubmed]
  26. Is a long-acting inhaled bronchodilator the first agent to use in stable chronic obstructive pulmonary disease?. Tashkin, D.P. Curr. Opin. Pulm. Med (2005) [Pubmed]
  27. Smoked marijuana as a cause of lung injury. Tashkin, D.P. Monaldi. Arch. Chest. Dis (2005) [Pubmed]
  28. The role of long-acting bronchodilators in the management of stable COPD. Tashkin, D.P., Cooper, C.B. Chest (2004) [Pubmed]
  29. Evidence implicating cocaine as a possible risk factor for HIV infection. Tashkin, D.P. J. Neuroimmunol. (2004) [Pubmed]
  30. Skin manifestations of inhaled corticosteroids in COPD patients: results from Lung Health Study II. Tashkin, D.P., Murray, H.E., Skeans, M., Murray, R.P. Chest (2004) [Pubmed]
  31. Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responses. Tashkin, D., Kesten, S. Chest (2003) [Pubmed]
  32. Airway effects of marijuana, cocaine, and other inhaled illicit agents. Tashkin, D.P. Curr. Opin. Pulm. Med (2001) [Pubmed]
  33. Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial. Tashkin, D., Kanner, R., Bailey, W., Buist, S., Anderson, P., Nides, M., Gonzales, D., Dozier, G., Patel, M.K., Jamerson, B. Lancet (2001) [Pubmed]
  34. HFA-BDP and its implications for the quiet zone. Tashkin, D.P. Respir. Med (2000) [Pubmed]
 
WikiGenes - Universities